Innovex International (INVX) Receives Buy Rating with $35 Target
Published on 5/13/2026

AI Summary
Summarized by AI from the source belowOn May 6, 2026, Citi initiated coverage of Innovex International, Inc. (INVX) with a Buy rating and a price target of $35. For Q1 2026, Innovex reported revenue of $239 million, reflecting a 1% decline year over year. The company expects Q2 revenue between $235 million and $245 million, along with adjusted EBITDA of $43 million to $48 million. CEO Adam Anderson stated that operational execution and new product launches contributed to stronger-than-expected results. Innovex also completed an acquisition during the quarter, enhancing its offshore market position.
Get the free market brief
Top stories and analysis, summarized. No spam, unsubscribe anytime.
Related News

Earnings
Cardinal Health Raises Price Target After Positive Profit Guidance
Aug 11

Earnings
Hnit-Baltic Uab Announcement: Financial Performance Updates
Aug 11

Earnings
Travere Therapeutics (TVTX) Expands Focus on Rare Disease Treatments
Aug 11

Earnings
Amazon (AMZN) Shares: Jeff Bezos Sells Over $4 Billion Worth
Aug 11